Natus Medical (BABY) Announces 2009 Q3 Results

Natus Medical Incorporated (Nasdaq: BABY) announced financial results for the three and nine months ended September 30, 2009.
For the third quarter ended September 30, 2009, Natus (BABY) reported revenue of $44.3M, compared to $41.7 M reported in the comparable quarter of the previous year. Net income was $3.7M, or $0.13 per diluted share, for the third quarter of 2009, compared with net income of $4.8M, or $0.17 per diluted share, for the third quarter of 2008.

For the nine months ended September 30, 2009, the Company reported net income of $6.8M, or $0.24 per diluted share, compared to net income of $11.2M, or $0.43 per diluted share, for the comparable period in 2008.

Natus (BABY) is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care.